What we should learn from the London Olympics.
What we should learn from the London Olympics.
复制标题
伦敦奥运会值得我们学习什么
DOI：
--
复制
发表时间：
2013
影响因子：
2.8
通讯作者：
S. Bonini
中科院分区：
文献类型：
--
作者：
M. Bonini;C. Bachert;C. Baena;A. Bedbrook;J. Brożek;G. Canonica;A. Cruz;W. Fokkens;R. Gerth van Wijk;L. Grouse;P. Hellings;P. Howarth;O. Kalayci;N. Khaltaev;P. Kuna;D. Larenas Linnemann;K. Nékám;S. Palkonen;N. Papadopoulos;T. Popov;D. Price;J. Rosado Pinto;G. Rasi;D. Ryan;B. Samoliński;G. Scadding;H. Schünemann;D. M. Thomas;M. Triggiani;A. Yorgancioglu;O. Yusuf;T. Zuberbier;R. Pawankar;J. Bousquet;S. Bonini
伦敦奥运会刚刚结束。官方报告将很快公布参加奥运会的运动员中有多少人患有哮喘。
然而，与过去一样，流行率数据通常会被使用吸入性β-2激动剂的运动员人数所扣除，根据2012年世界反兴奋剂机构（WADA）的新规则，在这种情况下，允许所有最常用的短效和长效药物，只要运动员自己声明使用。
这种自我报告将在很大程度上影响估计的准确性，这将无法区分临床哮喘和运动诱导的支气管收缩（EIB），而没有临床哮喘，最近要求。
The London Olympics have just finished. Official reports will soon become available on how many athletes participating in the games had asthma.
However, as in the past, prevalence data will often be deducted by the number of athletes using inhaled beta-2 agonists that, according to the new 2012 World Anti-Doping Agency (WADA) rules, were on this occasion permitted for all the most commonly used short-acting and long-acting drugs, just following a declaration of use made by the athletes themselves.
This self-reporting will largely influence the accuracy of estimates, which will not distinguish between clinical asthma and exercise-induced bronchoconstriction (EIB) without clinical asthma, as recently requested.
影响因子：
2.8
作者：
J. Mullol;C. Bachert;J. Bousquet
通讯作者：
J. Mullol;C. Bachert;J. Bousquet